Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine plus doxycycline versus doxycycline for rosacea
ChiCTR2400089784Phase 4Completed
- Sponsor
- Guizhou Provincial People's Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rosacea comparing Hydroxychloroquine plus doxycycline with Doxycycline plus hydroxychloroquine placebo (2 arms). Primary endpoints: Physical examination, Vital signs and 9 more. Started Sep 2024; status: completed.
02
Drugs
hydroxychloroquinedoxycycline
03
Conditions
rosacea
Beyond the preview
Go deeper on ChiCTR2400089784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089784.